We selected breast cancer SCP2 cells that are prone to bone metastasis [32] to explore the molecular mechanisms and found that SOST promoted the proliferation of breast cancer cells by enhancing the STAT3/TGF-β/KRAS signaling. The gene discussed is KRAS; the disease is breast carcinoma.